|
Hypertrophy
Citations 411-420 of 683 total displayed.
|
Past content
(since Mar 1999):
|
- Original Articles
Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease?
- Giovanni de Simone, Mary J. Roman, Michael H. Alderman, Maurizio Galderisi, Oreste de Divitiis, and Richard B. Devereux
Hypertension 2005;45:575-579; published online before print as doi:10.1161/01.HYP.0000158268.95012.08
[Abstract]
[Full text]
- Original Articles
Reduced Left Ventricular Functional Reserve in Hypertensive Patients With Preserved Function at Rest
- Michaela Kozakova, Alan G. Fraser, Simona Buralli, Armando Magagna, Antonio Salvetti, Ele Ferrannini, and Carlo Palombo
Hypertension 2005;45:619-624; published online before print as doi:10.1161/01.HYP.0000158838.34131.30
[Abstract]
[Full text]
- Original Articles
Effect of Treatment With Candesartan or Enalapril on Subcutaneous Small Artery Structure in Hypertensive Patients With Noninsulin-Dependent Diabetes Mellitus
- Damiano Rizzoni, Enzo Porteri, Carolina De Ciuceis, Intissar Sleiman, Luigi Rodella, Rita Rezzani, Silvia Paiardi, Rossella Bianchi, Giuseppina Ruggeri, Gianluca E.M. Boari, Maria Lorenza Muiesan, Massimo Salvetti, Francesca Zani, Marco Miclini, and Enrico Agabiti Rosei
Hypertension 2005;45:659-665; published online before print as doi:10.1161/01.HYP.0000153308.91043.97
[Abstract]
[Full text]
- Original Articles
Role of the B1 Kinin Receptor in the Regulation of Cardiac Function and Remodeling After Myocardial Infarction
- Jiang Xu, Oscar A. Carretero, Ying Sun, Edward G. Shesely, Nour-Eddine Rhaleb, Yun-He Liu, Tang-Dong Liao, James J. Yang, Michael Bader, and Xiao-Ping Yang
Hypertension 2005;45:747-753; published online before print as doi:10.1161/01.HYP.0000153322.04859.81
[Abstract]
[Full text]
- Original Articles
Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced Hypertension
- Oliver Jung, Ralf P. Brandes, In-Hae Kim, Frank Schweda, Ronald Schmidt, Bruce D. Hammock, Rudi Busse, and Ingrid Fleming
Hypertension 2005;45:759-765; published online before print as doi:10.1161/01.HYP.0000153792.29478.1d
[Abstract]
[Full text]
- Scientific Contributions
Is High Pulse Pressure a Marker of Preclinical Cardiovascular Disease?
- Giovanni de Simone, Mary J. Roman, Michael H. Alderman, Maurizio Galderisi, Oreste de Divitiis, and Richard B. Devereux
Hypertension published March 14, 2005, doi:10.1161/01.HYP.0000158268.95012.08
[Abstract]
- Scientific Contributions
Angiotensin II-Dependent Chronic Hypertension and Cardiac Hypertrophy Are Unaffected by gp91phox-Containing NADPH Oxidase
- Rhian M. Touyz, Chantel Mercure, Ying He, Danesh Javeshghani, Guoying Yao, Glaucia E. Callera, Alvaro Yogi, Nadheige Lochard, and Timothy L. Reudelhuber
Hypertension published March 7, 2005, doi:10.1161/01.HYP.0000158845.49943.5e
[Abstract]
- Hypertension Highlights
Putting the Brakes on Cardiac Hypertrophy: Exploiting the NO–cGMP Counter-Regulatory System
- George W. Booz
Hypertension 2005;45:341-346; published online before print as doi:10.1161/01.HYP.0000156878.17006.02
[Abstract]
[Full text]
- Original Articles
Asymptomatic Left Ventricular Systolic Dysfunction in Essential Hypertension: Prevalence, Determinants, and Prognostic Value
- Paolo Verdecchia, Fabio Angeli, Roberto Gattobigio, Mariagrazia Sardone, and Carlo Porcellati
Hypertension 2005;45:412-418; published online before print as doi:10.1161/01.HYP.0000154822.37141.f6
[Abstract]
[Full text]
- Scientific Contributions
Reduced Left Ventricular Functional Reserve in Hypertensive Patients With Preserved Function at Rest
- Michaela Kozakova, Alan G. Fraser, Simona Buralli, Armando Magagna, Antonio Salvetti, Ele Ferrannini, and Carlo Palombo
Hypertension published February 21, 2005, doi:10.1161/01.HYP.0000158838.34131.30
[Abstract]
|
|
